[go: up one dir, main page]

NO984632D0 - Medikament for optimalisering av slimviskositet og stimulering av tarmfunksjon - Google Patents

Medikament for optimalisering av slimviskositet og stimulering av tarmfunksjon

Info

Publication number
NO984632D0
NO984632D0 NO984632A NO984632A NO984632D0 NO 984632 D0 NO984632 D0 NO 984632D0 NO 984632 A NO984632 A NO 984632A NO 984632 A NO984632 A NO 984632A NO 984632 D0 NO984632 D0 NO 984632D0
Authority
NO
Norway
Prior art keywords
medication
stimulation
optimizing
intestinal function
mucus viscosity
Prior art date
Application number
NO984632A
Other languages
English (en)
Other versions
NO984632L (no
NO324877B1 (no
Inventor
Michel Hooreman
Original Assignee
Michel Hooreman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michel Hooreman filed Critical Michel Hooreman
Publication of NO984632D0 publication Critical patent/NO984632D0/no
Publication of NO984632L publication Critical patent/NO984632L/no
Publication of NO324877B1 publication Critical patent/NO324877B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19984632A 1996-04-05 1998-10-02 Anvendelse av en dominerende, eksocellulaer proteinase fremstilt ved dyrking av Streptomyces fradiae til fremstilling av et medikament. NO324877B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604310A FR2747045B1 (fr) 1996-04-05 1996-04-05 Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin
PCT/FR1997/000614 WO1997037681A1 (fr) 1996-04-05 1997-04-04 Medicament optimisant la viscosite des mucus et stimulant le fonctionnement de l'intestin

Publications (3)

Publication Number Publication Date
NO984632D0 true NO984632D0 (no) 1998-10-02
NO984632L NO984632L (no) 1998-12-03
NO324877B1 NO324877B1 (no) 2007-12-27

Family

ID=9490963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984632A NO324877B1 (no) 1996-04-05 1998-10-02 Anvendelse av en dominerende, eksocellulaer proteinase fremstilt ved dyrking av Streptomyces fradiae til fremstilling av et medikament.

Country Status (18)

Country Link
US (1) US6440413B1 (no)
EP (1) EP0891189A1 (no)
JP (1) JP4196225B2 (no)
CN (1) CN1168499C (no)
AP (1) AP1018A (no)
AU (1) AU735340B2 (no)
BR (1) BR9708506A (no)
CA (1) CA2251009C (no)
CZ (1) CZ298428B6 (no)
FR (1) FR2747045B1 (no)
HU (1) HUP9902421A3 (no)
NO (1) NO324877B1 (no)
NZ (1) NZ332107A (no)
OA (1) OA10894A (no)
PL (1) PL188157B1 (no)
RU (1) RU2198673C2 (no)
TR (1) TR199801976T2 (no)
WO (1) WO1997037681A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041296B1 (en) * 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit
DK1755656T3 (da) * 2004-05-24 2010-10-04 Novozymes As Enzymer til farmaceutisk anvendelse
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
JP2011505160A (ja) 2007-12-04 2011-02-24 ノボザイムス アクティーゼルスカブ 医薬用途のためのプロテアーゼ変異体
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
FR2998450A1 (fr) * 2012-11-26 2014-05-30 Dominique Hooreman Utilisation d'un complexe enzymatique dans l'alimentation des animaux d'elevage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133579A (en) * 1966-03-09 1968-11-13 Shionogi & Co Process for preparing proteases and enzymatic composition prepared thereby
GB1307516A (en) * 1969-02-21 1973-02-21 M Hooreman Enzymatic products which optimise the viscosity of mucuses and their applications
FR2600340A1 (fr) * 1986-06-20 1987-12-24 Hooremam Michel Procede de production d'un nouveau complexe proteolytique stimulant l'activite du pancreas et ses applications en zootechnie
RU2005488C1 (ru) * 1992-06-16 1994-01-15 Российская фармацевтическая компания "Фарма" Средство для лечения болезней соединительной ткани
RU2032744C1 (ru) * 1992-08-20 1995-04-10 Производственное объединение "Беллмедпрепараты" Штамм streptomyces sp. - продуцент рифамиционоксидазы и способ получения рифамициноксидазы
RU2034924C1 (ru) * 1993-03-03 1995-05-10 Акционерное общество "Биотехнология" Штамм streptomyces ornatus - продуцент кератиназы

Also Published As

Publication number Publication date
FR2747045B1 (fr) 1998-06-26
AP1018A (en) 2001-10-15
CZ318598A3 (cs) 1999-05-12
AU2393897A (en) 1997-10-29
TR199801976T2 (xx) 2000-10-23
HUP9902421A2 (hu) 1999-11-29
AP9801357A0 (en) 1998-12-31
NZ332107A (en) 2001-10-26
BR9708506A (pt) 1999-08-03
FR2747045A1 (fr) 1997-10-10
JP4196225B2 (ja) 2008-12-17
CN1168499C (zh) 2004-09-29
PL188157B1 (pl) 2004-12-31
CN1221347A (zh) 1999-06-30
JP2000509025A (ja) 2000-07-18
HUP9902421A3 (en) 2001-05-28
AU735340B2 (en) 2001-07-05
NO984632L (no) 1998-12-03
CA2251009A1 (fr) 1997-10-16
WO1997037681A1 (fr) 1997-10-16
CZ298428B6 (cs) 2007-10-03
RU2198673C2 (ru) 2003-02-20
OA10894A (fr) 2003-02-21
PL329161A1 (en) 1999-03-15
NO324877B1 (no) 2007-12-27
EP0891189A1 (fr) 1999-01-20
US6440413B1 (en) 2002-08-27
CA2251009C (fr) 2013-07-02

Similar Documents

Publication Publication Date Title
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20002784L (no) Forhindring og behandling av amyloidogen sykdom
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
HUT77655A (hu) Trombózisellenes gyógyszerkészítmény és eljárás előállítására
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
NO20001488D0 (no) Forhåndsfylte ampuller og tilvirkning derav
NO973365D0 (no) Fremgangsmåte for baking og tilhörende anordning
NO20010260D0 (no) Tarmbeskyttelsesbelagt farmasöytisk tablett og fremgangsmåte for fremstilling
IS4940A (is) Erýtrómýsín og aðferð við að framleiða þau
DK42093D0 (da) Administrationsmetode
NO308740B1 (no) Kinazolinderivater, anvendelse derav og farmasøytisk blanding
PL328608A1 (en) Novel derivatives of erythromycin, method of obtaining them and their therapeutic application as drugs
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
NO973288D0 (no) Blanding og anvendelse
NO951369D0 (no) Rörenhet og fremgangsmåte ved fremstilling av denne
BR9709450A (pt) Inibidores de produção do s-cd23 e da secreção de tnt
NO984632L (no) Medikament for optimalisering av slimviskositet og stimulering av tarmfunksjon
NO964200D0 (no) Behandling av autoimmun sykdom ved anvendelse av oral tolerisering og/eller Th2-forsterkende cytokiner
PL329213A1 (en) Novel derivatives of diarylmethylidene furane, method of obtaining them and their therapeutic application
NO20054619D0 (no) Sammensetninger og fremgangsmater for behandling av underjordiske formasjoner
PL323447A1 (en) Novel compounds - derivatives of 4-hydroxypiperisine, method of obtaining them and drug containing such derivatives
DK0670721T3 (da) Lægemiddel til behandling og forebyggelse af knogle- og ledsygdomme
DK0869952T3 (da) Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
NO985572L (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO962782D0 (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav

Legal Events

Date Code Title Description
MK1K Patent expired